A detailed history of Sheets Smith Wealth Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Sheets Smith Wealth Management holds 15,163 shares of ABBV stock, worth $2.73 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
15,163
Previous 15,520 2.3%
Holding current value
$2.73 Million
Previous $2.66 Million 12.51%
% of portfolio
0.37%
Previous 0.32%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$163.84 - $199.33 $58,490 - $71,160
-357 Reduced 2.3%
15,163 $2.99 Million
Q2 2024

Jul 30, 2024

SELL
$154.79 - $180.76 $24,147 - $28,198
-156 Reduced 1.0%
15,520 $2.66 Million
Q1 2024

May 08, 2024

SELL
$159.82 - $182.1 $11,666 - $13,293
-73 Reduced 0.46%
15,676 $2.85 Million
Q4 2023

Feb 06, 2024

SELL
$137.6 - $154.97 $69,075 - $77,794
-502 Reduced 3.09%
15,749 $2.44 Million
Q3 2023

Oct 23, 2023

SELL
$133.59 - $154.65 $178,877 - $207,076
-1,339 Reduced 7.61%
16,251 $2.42 Million
Q2 2023

Aug 09, 2023

SELL
$132.51 - $164.9 $4,107 - $5,111
-31 Reduced 0.18%
17,590 $2.37 Million
Q1 2023

May 26, 2023

BUY
$144.61 - $166.54 $2.53 Million - $2.91 Million
17,462 Added 10982.39%
17,621 $2.81 Million
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $2.54 Million - $2.92 Million
-17,544 Reduced 99.1%
159 $25,000
Q4 2022

Mar 08, 2023

SELL
$138.31 - $165.87 $8,160 - $9,786
-59 Reduced 0.33%
17,703 $2.86 Million
Q3 2022

Nov 01, 2022

BUY
$134.21 - $153.93 $407,729 - $467,639
3,038 Added 20.63%
17,762 $2.38 Million
Q2 2022

Jul 27, 2022

SELL
$137.62 - $174.96 $606,491 - $771,048
-4,407 Reduced 23.04%
14,724 $2.26 Million
Q1 2022

May 02, 2022

SELL
$131.98 - $163.75 $76,944 - $95,466
-583 Reduced 2.96%
19,131 $3.1 Million
Q4 2021

Jan 20, 2022

BUY
$107.43 - $135.93 $7,305 - $9,243
68 Added 0.35%
19,714 $2.67 Million
Q3 2021

Oct 15, 2021

SELL
$106.4 - $120.78 $16,917 - $19,204
-159 Reduced 0.8%
19,646 $2.12 Million
Q2 2021

Aug 03, 2021

SELL
$105.21 - $117.21 $8,732 - $9,728
-83 Reduced 0.42%
19,805 $2.23 Million
Q1 2021

Apr 23, 2021

BUY
$102.3 - $112.62 $36,725 - $40,430
359 Added 1.84%
19,888 $2.15 Million
Q4 2020

Jan 13, 2021

BUY
$80.49 - $108.67 $41,210 - $55,639
512 Added 2.69%
19,529 $2.09 Million
Q3 2020

Oct 26, 2020

BUY
$85.91 - $100.83 $48,710 - $57,170
567 Added 3.07%
19,017 $1.67 Million
Q2 2020

Jul 17, 2020

BUY
$73.37 - $98.18 $102,864 - $137,648
1,402 Added 8.22%
18,450 $1.81 Million
Q1 2020

Apr 28, 2020

BUY
$64.5 - $97.79 $29,347 - $44,494
455 Added 2.74%
17,048 $1.3 Million
Q4 2019

Jan 24, 2020

BUY
$72.13 - $90.25 $74,077 - $92,686
1,027 Added 6.6%
16,593 $1.47 Million
Q3 2019

Oct 28, 2019

SELL
$62.98 - $75.72 $220,555 - $265,171
-3,502 Reduced 18.37%
15,566 $1.18 Million
Q2 2019

Jul 12, 2019

BUY
$65.7 - $83.98 $1,839 - $2,351
28 Added 0.15%
19,068 $1.39 Million
Q1 2019

May 13, 2019

BUY
$77.14 - $90.79 $5,399 - $6,355
70 Added 0.37%
19,040 $1.53 Million
Q4 2018

Jan 11, 2019

BUY
$77.85 - $96.01 $125,182 - $154,384
1,608 Added 9.26%
18,970 $1.75 Million
Q3 2018

Oct 15, 2018

SELL
$88.91 - $98.84 $6,490 - $7,215
-73 Reduced 0.42%
17,362 $1.64 Million
Q2 2018

Jul 26, 2018

BUY
$89.78 - $106.23 $5,386 - $6,373
60 Added 0.35%
17,435 $1.62 Million
Q1 2018

Apr 09, 2018

SELL
$92.01 - $123.21 $1.06 Million - $1.42 Million
-11,526 Reduced 39.88%
17,375 $1.65 Million
Q4 2017

Jan 12, 2018

SELL
$89.56 - $98.21 $51,049 - $55,979
-570 Reduced 1.93%
28,901 $2.8 Million
Q3 2017

Oct 12, 2017

BUY
$69.85 - $89.22 $2.06 Million - $2.63 Million
29,471
29,471 $2.62 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Sheets Smith Wealth Management Portfolio

Follow Sheets Smith Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sheets Smith Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Sheets Smith Wealth Management with notifications on news.